We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves a Novel Medicine Invented at Scripps Research, for Treatment of Multiple Sclerosis

News   Mar 30, 2020 | Original story by Scripps Research

 
FDA Approves a Novel Medicine Invented at Scripps Research, for Treatment of Multiple Sclerosis
 
 
Advertisement
 

RELATED ARTICLES

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News

UK charity LifeArc has awarded Vicore Pharma approximately £1.5 million for the ATTRACT VP01 (C21) COVID-19 study.

READ MORE

Mapping Cholesterol Metabolism in the Brain

News

A team of researchers led by Swansea University have developed new technology to monitor cholesterol in brain tissue which could uncover its relation to neurodegenerative disease and pave the way for the development of new treatments.

READ MORE

Great Danes Help Identify Genes Associated With Fear

News

Researchers have identified a new genomic region and anxiety-related candidate genes associated with fearfulness in dogs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE